Physician profile
Dean Smith
NPI 1710939756
$16,050.43
in general payments reported to CMS, 2019-2025
8 companies · $5,693 in 2025
The $5,693 reported for 2025 was more than what 83% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,448 · 2020: $1,312 · 2021: $1,589 · 2022: $226 · 2024: $781 · 2025: $5,693.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $5,890 · Food and Beverage: $585.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $5,889.89 |
| Food and Beverage | $585.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Spineology INC. | $11,984.18 | 2019-2025 | |
| Abbott Laboratories | $1,955.03 | 2022-2025 | Proclaim, Penta, Infinity |
| Surgalign Spine Technologies, INC. | $1,077.30 | 2021 | |
| Globus Medical, INC. | $707.00 | 2024 | Excelsiusgps Robotic Navigation System |
| Acera Surgical, INC. | $135.00 | 2025 | Restrata Wound Matrix |
| Horizon Therapeutics Plc | $86.27 | 2019-2021 | |
| Alafair Biosciences, INC. | $77.06 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $28.59 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dean Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.